Target intelligence / Profile preview

Human immunodeficiency virus replication (HIV replication)

Target
HIV replication
Molecular classification
Enzyme, Receptor, Viral protein, Other
01

Overview

Human immunodeficiency virus (HIV) replication is the multi-stage biological process by which HIV infects host cells and generates new progeny (NIH, 2021). The cycle begins with the attachment of the viral gp120 protein to the host CD4 receptor and a co-receptor (CCR5 or CXCR4), followed by gp41-mediated membrane fusion (Nature Reviews Microbiology, 2018). Once the viral core enters the cytoplasm, reverse transcriptase converts the viral RNA genome into double-stranded DNA, which is then integrated into the host cell's genome by the enzyme integrase (StatPearls, 2023). The host's cellular machinery then transcribes and translates the integrated proviral DNA into viral RNA and polyproteins. These components assemble at the cell membrane to form immature virions that bud off; subsequently, the viral protease enzyme cleaves the polyproteins to produce mature, infectious virus particles (PubMed, 2020). Therapeutic strategies, collectively known as antiretroviral therapy (ART), target these specific enzymatic and entry steps to suppress viral load and prevent the progression to AIDS (NIH, 2021).

Other names
HIV life cycleHIV-1 replication cycleHIV infection cycleViral replication
02

Mechanism of action

Inhibition of viral enzymes including reverse transcriptase, integrase, and protease; blockade of viral entry via CCR5 antagonism and fusion inhibition; and disruption of capsid assembly and disassembly (StatPearls, 2023; NIH, 2021).

03

Biological functions

Viral life cycleReverse transcriptionDNA integrationProteolysisViral entry
04

Disease associations

Infection
05

Safety considerations

Development of multi-drug resistanceMitochondrial toxicityHepatotoxicityLipodystrophy and metabolic syndromeImmune reconstitution inflammatory syndrome (IRIS)
06

Interacting drugs

Zidovudine

7 more in the full profile.

07

Biomarkers

HIV-1 RNA viral loadCD4+ T-cell countHLA-B*5701 alleleViral tropism assay

Beyond the preview

Go deeper on Human immunodeficiency virus replication (HIV replication).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human immunodeficiency virus replication (HIV replication).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call